By Hira Verma | Chair & President
In 2015, K.I.D.S. IQ Project began raising money to fund scientific research projects aimed at advancing a drug treatment for Kleefstra Syndrome (KS). With the help of our partner organization, GlobalGiving Foundation, we made great progress toward our funding target. Since the launch of our efforts, we raised over C$300,000 across the world.
Early in 2016, K.I.D.S. IQ Project launched a formal process to solicit research proposals from scientific teams around the world. These teams were screened and identified over the course of the past year to ensure that their experience bases and interests matched the needs of our Kleefstra Syndrome research goals. Since launching our formal research solicitation process, K.I.D.S. IQ Project received a number of compelling proposals which were reviewed by our Scientific Advisory Board (SAB). The SAB is multi-disciplinary team which brings together a mix of research and commercial experience covering drug discovery, epigenetics, genetics, neurodevelopmental disorders, preclinical and clinical trials, venture capital and biotech management. The SAB completed its review and project selection process in early June. Based on recommendations of the SAB, K.I.D.S. IQ Project expects to begin funding the initial phases of two research projects in the coming months. More details on these two research projects will be provided once funding begins.
Our progress to date would not be possible without our donors. Once again, we thank you for your continued support!
Links:
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
